Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
(Q39202247)
scientific article published on 13 July 2001
scientific article published on 13 July 2001
Language:
Current Data About
Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
other details
| description | scientific article published on 13 July 2001 |
External Links
| (P356) |
10.1074/JBC.M105670200
|
| (P698) |
11454872
|